RELIANCE GLOBAL GROUP INC (RELI)

US75946W4050 - Common Stock

3.11  +1.91 (+159.17%)

After market: 3.2 +0.09 (+2.89%)

Fundamental Rating

2

Taking everything into account, RELI scores 2 out of 10 in our fundamental rating. RELI was compared to 141 industry peers in the Insurance industry. RELI has a bad profitability rating. Also its financial health evaluation is rather negative. RELI has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year RELI has reported negative net income.
In the past year RELI has reported a negative cash flow from operations.
In the past 5 years RELI always reported negative net income.
In the past 5 years RELI always reported negative operating cash flow.

1.2 Ratios

RELI has a worse Return On Assets (-110.45%) than 99.29% of its industry peers.
The Return On Equity of RELI (-682.13%) is worse than 97.86% of its industry peers.
Industry RankSector Rank
ROA -110.45%
ROE -682.13%
ROIC N/A
ROA(3y)-46.88%
ROA(5y)-36.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RELI has a better Gross Margin (70.90%) than 97.14% of its industry peers.
RELI's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for RELI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y5.07%

3

2. Health

2.1 Basic Checks

RELI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RELI has less shares outstanding
The number of shares outstanding for RELI has been increased compared to 5 years ago.
Compared to 1 year ago, RELI has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.40, we must say that RELI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of RELI (-3.40) is better than 67.86% of its industry peers.
A Debt/Equity ratio of 3.74 is on the high side and indicates that RELI has dependencies on debt financing.
RELI's Debt to Equity ratio of 3.74 is on the low side compared to the rest of the industry. RELI is outperformed by 97.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Altman-Z -3.4
ROIC/WACCN/A
WACC6.25%

2.3 Liquidity

RELI has a Current Ratio of 1.13. This is a normal value and indicates that RELI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RELI (1.13) is better than 80.71% of its industry peers.
RELI has a Quick Ratio of 1.13. This is a normal value and indicates that RELI is financially healthy and should not expect problems in meeting its short term obligations.
RELI has a better Quick ratio (1.13) than 80.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13

2

3. Growth

3.1 Past

RELI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -193.31%.
Looking at the last year, RELI shows a decrease in Revenue. The Revenue has decreased by -3.44% in the last year.
Measured over the past years, RELI shows a very strong growth in Revenue. The Revenue has been growing by 68.20% on average per year.
EPS 1Y (TTM)-193.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1236.7%
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y23.44%
Revenue growth 5Y68.2%
Sales Q2Q%4.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

RELI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RELI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RELIANCE GLOBAL GROUP INC

NASDAQ:RELI (12/23/2024, 8:00:01 PM)

After market: 3.2 +0.09 (+2.89%)

3.11

+1.91 (+159.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-07 2024-11-07
Earnings (Next)N/A N/A
Inst Owners2.35%
Inst Owner Change-84.65%
Ins Owners5.66%
Ins Owner Change0.57%
Market Cap5.32M
Analysts82.86
Price TargetN/A
Short Float %2.67%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-66.76
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.49
FCFYN/A
OCF(TTM)-1.45
OCFYN/A
SpS8.23
BVpS1.65
TBVpS-5.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -110.45%
ROE -682.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.9%
FCFM N/A
ROA(3y)-46.88%
ROA(5y)-36.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5Y5.07%
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 3.74
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.31%
Cap/Sales 0.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z -3.4
F-Score2
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)28.02%
Cap/Depr(5y)32.15%
Cap/Sales(3y)4.72%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1236.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y23.44%
Revenue growth 5Y68.2%
Sales Q2Q%4.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y46.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.9%
OCF growth 3YN/A
OCF growth 5YN/A